Comparison
Evaluate (Evaluate Pharma) is built for strategy, finance and competitive-intelligence teams that need consensus forecasts and valuation, with pricing tailored to each organization and not published. Salesmotion for Life Sciences is built for the people selling into sponsors, with signals, verified contacts and outreach, from $85/mo on a monthly contract.
By Semir JahicCEO & Co-Founder, SalesmotionLast reviewed | Feature | Evaluate | Salesmotion for Life Sciences |
|---|---|---|
| Primary Job | Consensus forecasting, valuation & market analysis | Commercial sponsor discovery, signals & outreach |
| Core Audience | Strategy, corporate development, finance & CI teams | BD, sales, and commercial teams (CROs/CDMOs/labs) |
| Core Data | Product- and company-level forecasts, pipeline and competitive intelligence | Sponsors, trials, buying signals and verified decision-maker contacts (email + phone) |
| AI | Research AI: Ask Ella and Norstella Atlas CI | Signal, Research and Outreach agents; outreach drafted from the trigger |
| Delivery | Evaluate products and data feeds | Native Salesforce & HubSpot sync; REST API and MCP server |
| Data Timing | Consensus forecasts, updated as analysts revise | Real-time ingestion from 40+ live sources |
| Pricing | Custom, enterprise-only | $85/mo for individuals. Custom pricing for teams & enterprise. |
| Rating (G2) | — | 4.8/5 |
Evaluate is a commercial-intelligence and forecasting business for life sciences, founded in London in 1996 and part of Norstella, the group that also owns Citeline, MMIT, Panalgo, Skipta and The Dedham Group. Its flagship, Evaluate Pharma, is the reference dataset for consensus drug-sales forecasts: 1.5 million+ consensus forecasts of 10,000 products dating back to 2003, with consensus forecasts for almost 6,000 drugs. Evaluate Omnium adds risk and return modeling for drug assets.
Around that core, Evaluate sells Evaluate Epi, Evaluate Medtech, Datamonitor Healthcare, Biomedtracker, CDMO Intelligence, a Competitive Intelligence product and data feeds. Ask Ella is its AI analyst: it lives inside the Evaluate product and returns sourced, citable answers to questions asked in plain English. Norstella Atlas CI is a competitive intelligence agent for pharma and biotech.
Evaluate is built for forecasting, valuation, market sizing and competitive intelligence. Its pricing page addresses pharma, financial services, consulting, medtech, CDMO and CRO buyers, and pricing is tailored to each organization.
Best for: Strategy, corporate development, finance and competitive-intelligence teams that need consensus forecasts, valuation and market analysis
Pricing: Evaluate does not publish list pricing; contracts are quoted per organization; its pricing page states pricing is tailored to each organization's data requirements, users and workflows.
Salesmotion for Life Sciences is an AI-native sponsor-intelligence platform for the commercial side of life sciences: CROs, CDMOs, bioanalytical labs, and tools and equipment vendors selling into biotech and pharma. Where a forecasting platform answers "what is this market or asset worth?", Salesmotion answers the seller's question: "which sponsors should I pursue, why now, who do I contact, and what do I say?"
It continuously discovers and classifies sponsors from clinical trials (live from ClinicalTrials.gov and 40+ sources), regulatory filings, funding events, investor decks and the open web, ranks 38,400+ drug developers and 410,000+ trials by fit to what you sell, and surfaces buying-window signals such as first-in-human, phase transitions, readouts and funding as they happen.
It carries the commercial execution layer: verified decision-maker contacts with email and phone, AI outreach anchored to the real trigger, and native Salesforce and HubSpot sync. Cytel, a 2,000+ person clinical-research organization, consolidated five research sources into Salesmotion and cut research time by 50%.
Best for: Life-science BD and sales teams that need real-time sponsor discovery, buying signals, verified contacts, and outreach in one CRM-connected platform
G2 rating: 4.8/5
Pricing: $85/mo for individuals — flexible monthly billing. Custom pricing for teams and enterprise on request.
How Evaluate and Salesmotion for Life Sciences stack up across key capabilities.
| Feature | Evaluate | Salesmotion for Life Sciences |
|---|---|---|
| Consensus Forecasts | Core strength: 1.5 million+ consensus forecasts back to 2003 | Built for selling; pairs with a forecasting source |
| Valuation & Market Sizing | Deep: drug-level consensus forecasts, worldwide and US-specific | Fit-ranking of sponsors by what you sell |
| Sponsor Discovery for Selling | Asset- and market-oriented research | Continuous discovery ranked by fit to what you sell |
| Signals | Forecast, pipeline and competitive-intelligence updates | Real-time intent-tagged signals as buying windows open |
| Decision-Maker Contacts | Product, company and market data | Verified contacts with email and phone, per sponsor |
| AI | Research AI (Ask Ella): sourced, citable answers in plain English | AI outreach drafts anchored to the trigger |
| CRM & Data Delivery | Data feeds | Native Salesforce & HubSpot |
| Predictive Analytics | Evaluate Omnium: risk and return modeling on assets | AI fit-scoring of sponsors for commercial fit |
| Buying Process | Tailored quote or RFP | Live in days; no implementation project |
We held 55 sales and customer calls between August and October 2026, 17 of them with life sciences teams. The recurring theme was timing: reaching a sponsor before the vendor decision is made.
“if we reach out too late, I don't care how well my messages ... If they've already signed for like their phase two study, they're just not going to be interested.”
“So how confident are you that your data is up to date?”
“the hope would be that we would have one solution, not like multiple solutions.”
Evaluate does not publish list pricing; contracts are quoted per organization; its pricing page states pricing is tailored to each organization's data requirements, users and workflows. The page offers a tailored quote or an RFP route, with separate entry points for pharma, financial services, consulting, medtech, CDMO and CRO buyers.
Salesmotion for Life Sciences uses flexible, monthly pricing: individuals from $85/mo a month, with custom team and enterprise pricing (unlimited users) and no annual lock-in. For a tailored quote based on your therapeutic areas, service lines, and integrations, book a demo.
The honest trade-off: these tools barely overlap. Evaluate is the reference source for consensus forecasts, valuation and market analysis, and if that is your job it is the right tool. Evaluate answers "what is this market or asset worth?" Salesmotion answers "which sponsors do I sell to, who do I call, and what do I send?" Evaluate is built for forecasting and valuation; Salesmotion is built for the selling motion. See how Cytel consolidated five research sources into Salesmotion and cut research time by 50%.
We'd rather you pick the right tool than the wrong one. Salesmotion isn't for everyone — here's when another option on this page is the smarter call.
“All of the vendors that I've worked with, all of the onboarding that I have had to deal with, I will say, hands down, Salesmotion was the easiest that I have had.”
Lyndsay Thomson
Head of Sales Operations, Cytel
Salesmotion gives your reps the account intelligence they need to book more meetings and close bigger deals.
Evaluate is a forecasting and commercial-intelligence platform rather than a sales tool. Evaluate Pharma and its sister products serve strategy, corporate-development, finance and competitive-intelligence teams with consensus drug-sales forecasts, valuation and market analysis, and its AI analyst, Ask Ella, answers research questions against that data. Salesmotion for Life Sciences is the commercial-execution tool: discovering sponsors to sell to, spotting buying windows, reaching decision-makers, and drafting outreach.
Evaluate does not publish list pricing; contracts are quoted per organization; its pricing page states pricing is tailored to each organization's data requirements, users and workflows. Salesmotion publishes its entry price: individuals from $85/mo a month on a monthly contract, with custom team and enterprise pricing.
Yes. Ask Ella is Evaluate's AI analyst. It lives inside the Evaluate product and gives sourced, citable answers to questions asked in plain English, and Norstella Atlas CI is a competitive intelligence agent for pharma and biotech. Both are research AI. Salesmotion's agents are built for selling: they monitor sponsors for buying signals, write the account brief and draft the outreach.
Only if you weren't using Evaluate for forecasting. Evaluate is the reference source for consensus forecasts and valuation, and it is the right tool for that work. The two serve different jobs: Evaluate informs strategy and finance decisions, while Salesmotion drives the commercial selling motion. Teams that use Evaluate for forecasting and Salesmotion for BD and sales are using each for what it does best.
For the selling motion, Salesmotion for Life Sciences. Evaluate does serve CROs and CDMOs, including a CDMO Intelligence product, with research and market data. Salesmotion covers what a BD team does with that picture: ranking sponsors by fit, flagging buying windows from trial and funding events in real time, providing verified contacts and drafting the outreach.
Evaluate is part of Norstella, the group that also owns Citeline, MMIT, Panalgo, Skipta and The Dedham Group. Evaluate's own timeline dates its joining Norstella to 2020. So Evaluate (forecasting) and Citeline (pipeline and trials) are sister brands under the same parent.
A Signal Agent, Research Agent, and Outreach Agent — working 24/7 so your team spends less time researching and more time closing.
